In Perioperative Immunotherapy Advances: Insights from CheckMate-77T and KEYNOTE-671, our panel delves into the following ...

Cancer care in 2026 now relies on immunotherapy, targeted therapy, and multimodality treatment, even in early stages, ...

Dr. Ashwani Kumar Sharma explains why a persistent cough lasting over three weeks should not be ignored, highlighting key lung cancer symptoms, diagnosis, and treatment options.

Ongoing Phase 3 full approval clinical trial of ateganosine holds high probability of technical success for interim and full ...

Scientists have identified molecular switches that allow aggressive cancers to change identity and resist treatment, opening paths to more precise therapies.

Cancer survivor Branwen Hywel said delays in diagnosis and treatment add 'so much stress to the already horrific situation' ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...

Genprex to receive Japanese and EU patents for Reqorsa Gene Therapy in combination with immunotherapies to treat cancer: Austin, Texas Wednesday, February 25, 2026, 17:00 Hrs [IST ...

Updated data for casdatifan in late-line kidney cancer demonstrated median progression-free survival (PFS) of 15.1 months and a confirmed overall response rate (cORR) of 45% for the 100mg once-daily ...

The itch crept up my back, across my stomach and along my arms and legs. It flared during my morning runs and followed me to the office. It was particularly acute at night.